OR Royalties Inc. (NYSE:OR) Receives Consensus Rating of "Hold" from Analysts

Key Points

• OR Royalties has a consensus analyst rating of Hold, based on nine research firms. The average 12-month price target is $40.50, with analysts split between sell, hold, buy, and strong buy ratings.
• The stock recently traded at $29.17, well below its 200-day moving average of $37.84 and its 52-week high of $48.06. The company has a market cap of $5.46 billion and a beta of 0.74.
• OR Royalties reported Q1 earnings of $0.40 per share, beating estimates, and recently raised its quarterly dividend to $0.065 per share. The annualized dividend is $0.26, for a yield of about 0.9%.

Shares of OR Royalties Inc. (NYSE:OR - Get Free Report) have been given an average rating of "Hold" by the nine research firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, four have given a hold recommendation, three have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target price among brokers that have covered the stock in the last year is $40.50.

OR has been the subject of several recent research reports. Zacks Research cut shares of OR Royalties from a "hold" rating to a "strong sell" rating in a report on Monday, July 13th. Wall Street Zen lowered shares of OR Royalties from a "buy" rating to a "hold" rating in a research note on Saturday, June 6th. Royal Bank Of Canada cut their price target on shares of OR Royalties from $50.00 to $45.00 and set an "outperform" rating on the stock in a research report on Thursday, July 9th. Scotiabank decreased their price objective on OR Royalties from $51.00 to $42.00 and set a "sector perform" rating for the company in a report on Tuesday, July 14th. Finally, Jefferies Financial Group lowered their target price on OR Royalties from $40.00 to $34.00 and set a "hold" rating on the stock in a research report on Monday, July 6th.

OR Royalties Stock Performance

NYSE:OR opened at $29.17 on Friday. The stock has a 50-day simple moving average of $32.75 and a 200 day simple moving average of $37.84. OR Royalties has a 52-week low of $27.40 and a 52-week high of $48.06. The company has a market cap of $5.46 billion, a PE ratio of 21.77 and a beta of 0.74.

OR Royalties (NYSE:OR - Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The basic materials company reported $0.40 earnings per share for the quarter, topping analysts' consensus estimates of $0.34 by $0.06. The firm had revenue of $102.83 million during the quarter, compared to the consensus estimate of $103.27 million. OR Royalties had a return on equity of 15.10% and a net margin of 78.09%. On average, research analysts predict that OR Royalties will post 1.27 earnings per share for the current fiscal year.

OR Royalties Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Tuesday, June 30th were paid a $0.065 dividend. This is a positive change from OR Royalties's previous quarterly dividend of $0.06. This represents a $0.26 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date was Tuesday, June 30th. OR Royalties's dividend payout ratio is 18.66%.

Institutional Investors Weigh In On OR Royalties

Several large investors have recently made changes to their positions in OR. State of Wyoming bought a new position in shares of OR Royalties in the first quarter valued at $28,000. FIL Ltd bought a new stake in OR Royalties during the fourth quarter worth $29,000. Banque Cantonale Vaudoise acquired a new stake in OR Royalties in the first quarter valued at $37,000. Grove Bank & Trust acquired a new stake in OR Royalties in the second quarter valued at $32,000. Finally, Assetmark Inc. bought a new position in shares of OR Royalties in the 4th quarter valued at about $36,000. Institutional investors and hedge funds own 68.52% of the company's stock.

OR Royalties Company Profile

OR Royalties PLC NYSE: OR is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company's core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.